CYDY vs GALT: stock comparison and AI forecast
Cytodyn Inc. (CYDY) and Galectin Therapeutics Inc (GALT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CYDY Cytodyn Inc.
- Market Cap
- $332M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
GALT Galectin Therapeutics Inc
- Market Cap
- $338M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CYDY and GALT have similar market capitalizations ($332M and $338M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CYDY | GALT |
|---|---|---|
| Market Cap | $332M | $338M |
| EPS | $-0.04 | $-0.50 |
Profitability & Margins
| Metric | CYDY | GALT |
|---|---|---|
| ROA | -272.5% | -187.8% |
| ROIC | 128.9% | 11.4% |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | CYDY | GALT |
|---|---|---|
| Current Ratio | 0.38x | 0.10x |
| Interest Coverage | -315.1x | -9.2x |
| Working Capital | -$31M | -$137M |
Cash Flow
| Metric | CYDY | GALT |
|---|---|---|
| Operating Cash Flow | -$20M | -$16M |
Income Statement
| Metric | CYDY | GALT |
|---|---|---|
| Operating Income | -$40M | -$16M |
| Net Income | -$52M | -$28M |
| R&D Expense | – | $9M |
Dividend & Shareholder Information
| Metric | CYDY | GALT |
|---|---|---|
| Shares Outstanding | 1470M | 101M |
CYDY vs GALT: stock comparison and AI forecast
Which is bigger, CYDY or GALT?
CYDY and GALT have similar market capitalizations ($332M and $338M).
Which one does Intratio's AI model rank higher, CYDY or GALT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.